Genetic testing for hereditary nonpolyposis colorectal cancer

Current Opinion in Gastroenterology

Volumn 19, Issue 1, 2003, Pages 57-63

  Jagadeesh, Deepa ^a,b,c   Syngal, Sapna ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASE MISPAIRING; CANCER DIAGNOSIS; CANCER RISK; COLORECTAL CANCER; DIAGNOSTIC TEST; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC PROCEDURES; HIGH RISK POPULATION; HUMAN; PRACTICE GUIDELINE; REVIEW;

EID: 0037215506     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200301000-00010     Document Type: Review

References (33)

1. Lynch HT, de la Chapelle A: Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 1999, 36:801-818.
2. Syngal S, Fox E, Li C, et al.: Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. JAMA 1999, 282:247-253.
3. Wagner A, Hendriks Y, Meijers-Heijboer EJ, et al.: Atypical HNPCC owing to MSH6 germline mutations: Analysis of a large Dutch pedigree. J Med Genet 2001, 38:318-322.
4. Plaschke J, Kruger S, Pistorius S, el al.: Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer 2002, 97:643-648.
5. Liu T, Yan H, Kuismanen S, et al.: The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Research 2001, 61:7798-7802.
6. Carayol J, Khlat M, Maccario J, Bonaiti-Pellie C: Hereditary non-polyposis colorectal cancer: Current risks of colorectal cancer largely overestimated. J Med Genet 2002, 39:335-339.
7. Vasen HFA, Stormorken A, Menko FH, et al.: MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary non-polyposis colorectal cancer families. J Clin Oncol 2001, 19:4074-4080.
8. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al.: A National Cancer Institute worshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J Nat Cancer Inst 1997, 88:1758-1762.
9. Raedle J, Trojan J, Brieger A, et a.: Bethesda guidelines: Relation to microsalellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 2001, 135:566-576.
10. Wiillenweber H-P, Sutter C, Autschbach F, et al.: Evaluation of Bethesda guidelines in relation to microsatallite instability. Dis Colon Rectum 2001, 44:1281-1289.
11. Syngal S, Fox EA, Eng C, Kolodner RD, et al.: Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000, 37:641-645.
12. Terdiman JP, Gum JR, Conrad PG, et al.: Efficient detection of hereditary non-polyposis colorectal cancer gene carriers by screening for tumor microsatallite instability before germline genetic testing. Gastroenterology 2001, 120:21-30.
13. Boland CR, Thibodeau SN, Hamilton SR, et al.: A National Cancer Institute Workshop on Microsatallite Instability for cancer detaction and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248-5257.
14. Samowitz WS, Curtin K, Lin HH, et al.: The colon cancer burden of genetically defined hereditary non-polyposis colon cancer. Gastroentarology 2001, 121:830-838.
15. Lindor NM, Burgart IJ, Leontovich O, et al.: Immunohistochemistry versus microsatallite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043-1048.
16. Scartozzi M, Bianchi F, Rosati S, et al.: Mutations of hMLH1 and hMSH2 in patients with suspected hereditary non-polyposis colorectal cancer: Correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 2002, 20:1203-1208.
17. Berends MJW, Hollema H, Wu Y, Sluis TVD, et al.: MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia. Int J Cancer 2001, 92:398-403.
18. Wahlberg SS, Schmeits J, Thomas G, et al.: Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002, 62:3485-3492.
19. Rabelo R, Foulkes W, Gordon PH, et al.: Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families. Dis Colon Rectum 2001, 44:437-446.
20. Holinski-Feder E, Muller-Koch Y, Friedl W, et al.: DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods 2001, 47:21-32.
21. Jakubowska A, Gorski B, Kurzawski G, et al.: Optimization of experimental conditions for RNA based sequenceing of MLH1 and MSH2 genes. Human Mutation 2001, 17:52-60.
22. Kurzawski G, Safranow K, Suchy J, et al.: Mutation analysis of MLH1 and MSH2 genes parroted by denaturing high-performance liquid chromatography. J Biochem Biophys Methods 2002, 51:89-100.
23. Wijnen J, van der Klift H, Vasen H, et al.: MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998, 20:326-328.
24. Charbonnier F, Olschwang S, Wang Q, et al.: MSH2 in contrast to MLHt is frequently inactivated by exonic promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Research 2002, 62:848-853.
25. Wang Y, Freidl W, Sengteller M, et al.: A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1. Human Mutation 2002, 19:279-286.
26. Batra S, Valdimarsdottir H, McGovern M, et al.: Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. Am J Gastroenterol 2002, 97:729-733.
27. Schroy PC, Barrison AF, Ling BS, et al.: Family history and colorectal cancer screening: A survey of physician knowledge and practice patterns. Am J Gastroenterol 2002, 97:1031-1036.
28. American Gastroenterology Association: American Gastroenterological Association medical position statement: Hereditary colorectal cancer and genetic testing. Gastroenterology 2001, 121:195-197.
29. American Gastroenterology Association: AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001, 121:198-213.
30. Wong N, Lasko O, Rabelo R, et al.: Genetic counseling and interpretation of genetic tests in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 2001, 44:271-279.
31. Ramsey S, Clarke L, Etzioni R, et al.: Coat-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001, 135:577-588.
32. Aktan-Collan K, Haukkala A, Jukka-Pekka M, et al.: Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary nonpolyposis colorectal cancer. J Med Genet 2001, 38:787-792.
33. Dove-Edwin I, Boks O, Goff S, et al.: The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002, 94:1708-1712.